HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5-aminodaunorubicin (DR 22)

Also Known As:

DR 22; DR-22

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Alswelmi, Farhan Khashim: 1 article (01/2017)
2.	Parrey, Mujeeb Ur Rehman: 1 article (01/2017)
3.	Horii, Takahiro: 1 article (12/2010)
4.	Murakami, Tomoaki: 1 article (12/2010)
5.	Nishijima, Kazuaki: 1 article (12/2010)
6.	Ota, Masafumi: 1 article (12/2010)
7.	Sakamoto, Atsushi: 1 article (12/2010)
8.	Yoshimura, Nagahisa: 1 article (12/2010)

Related Diseases

1.	Diabetic Retinopathy (Retinopathy, Diabetic) 12/01/2010 - "We surveyed a consecutive series of 76 eyes from 60 patients with DR (22 mild nonproliferative diabetic retinopathy [NPDR]; 43 moderate NPDR; 9 severe NPDR; 2 proliferative diabetic retinopathy [PDR]) who underwent Spectralis OCT, fluorescein angiography (FA), and color fundus photography on the same day. " 01/01/2017 - "Cataract was found to be the main cause of VI [51 cases (30.7%)] followed by refractive error (RE) [41 cases (24.7%)] and diabetic retinopathy (DR) [22 cases (13.2%)]. "
2.	Refractive Errors (Refractive Error) 01/01/2017 - "Cataract was found to be the main cause of VI [51 cases (30.7%)] followed by refractive error (RE) [41 cases (24.7%)] and diabetic retinopathy (DR) [22 cases (13.2%)]. "
3.	Infections 01/01/2023 - "In addition, when applied to the 123 patients still in the ICU at days 5-7 after admission, IPP similarly enriched the number of patients with ICU-acquired infections in the immunosuppressed group (26%), in comparison with low mHLA-DR (22%). "
4.	Cataract (Cataracts) 01/01/2017 - "Cataract was found to be the main cause of VI [51 cases (30.7%)] followed by refractive error (RE) [41 cases (24.7%)] and diabetic retinopathy (DR) [22 cases (13.2%)]. "

Related Drugs and Biologics

1.	Fluorescein (Funduscein)
2.	indolepropanol phosphate (IPP)